Home/Filings/4/0001567619-22-017697
4//SEC Filing

Payne Fletcher 4

Accession 0001567619-22-017697

CIK 0000882361other

Filed

Sep 20, 8:00 PM ET

Accepted

Sep 21, 6:06 PM ET

Size

9.4 KB

Accession

0001567619-22-017697

Insider Transaction Report

Form 4
Period: 2022-09-19
Payne Fletcher
SR VP & Chief Fin. Officer
Transactions
  • Purchase

    Common Shares

    2022-09-19$0.68/sh+10,000$6,77510,000 total(indirect: By Trust)

Issuer

Aptose Biosciences Inc.

CIK 0000882361

Entity typeother

Related Parties

1
  • filerCIK 0001650476

Filing Metadata

Form type
4
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 6:06 PM ET
Size
9.4 KB